Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S. 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
SAN DIEGO, Nov. 14, 2016 -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that Andy Rasdal, Chief Executive Officer and Bill Plovanic, Chief Financial Officer of Obalon will present at two upcoming investor conferences:
- Stifel 2016 Healthcare Conference
Wednesday, November 16, 2016 at 8:00 a.m. Eastern Time
Lotte New York Palace Hotel, New York, NY
Webcast Available at: http://wsw.com/webcast/stifel5/obln - Canaccord Genuity Medical Technologies & Diagnostics Forum
Thursday, November 17, 2016 at 4:00 p.m. Eastern Time
Westin Grand Central, New York, NY
Webcast Available at: http://wsw.com/webcast/canaccord24/obln
Live audio webcasts of the presentations can be accessed at the links above. Replays of the webcasts will be available for 90 days following each presentation.
About Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. (NASDAQ:OBLN), is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit www.obalon.com.
Investor Contact: William Plovanic Chief Financial Officer Obalon Therapeutics, Inc. Office: +1 760 607 5103 [email protected] Media Contact: Megan Driscoll EvolveMKD Office Phone: +1 646 517 1565 [email protected]
